Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib
Fabio P. S. Santos, Yesid Alvarado, Hagop Kantarjian, Dushyant Verma, Susan O'Brien, Gloria Mattiuzzi, Farhad Ravandi, Gautam Borthakur, Jorge CortesVolume:
117
Year:
2011
Language:
english
Pages:
10
DOI:
10.1002/cncr.25533
File:
PDF, 286 KB
english, 2011